Light sensitivity, or photophobia, is a frequent symptom of migraine headaches, which affect nearly 15 percent of the world's population. A new study, led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and ...
May 17, 2016
0
236
Migraine researchers and clinicians are growing excited about a new class of drugs called Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies, which are showing promise in treating high-frequency episodic migraine ...
Jun 17, 2015
0
25
In a study published in Human Genetics, QUT Professor Dale Nyholt and QUT Ph.D. researcher Rafiqul Islam, describe using large-scale genome-wide associations studies (GWAS) summary statistics to analyze hundreds of thousands ...
Feb 23, 2023
0
88
Migraine is the third most prevalent illness in the world and causes suffering for tens of millions of people. In fact, nearly 1 in 4 U.S. household includes someone with migraines.
Nov 25, 2019
0
6
(HealthDay)—Vitamin D supplementation could reduce headache attacks per month and headache days per month among migraine patients, according to a review published in the December issue of The American Journal of Emergency ...
Jan 11, 2022
0
58
(Medical Xpress)—A team of researchers with members from across Europe has discovered the mechanism by which the sleeping sickness parasite overcomes the immune system in humans. In their paper published in the journal ...
People with persistent back pain or persistent headaches are twice as likely to suffer from both disorders, a new study from the University of Warwick has revealed.
Sep 19, 2019
0
10
A revised version of a surgical procedure to treat severe chronic migraine headaches led to significant symptom relief more than 90 percent of the time in patients treated at Massachusetts General Hospital (MGH). Physicians ...
Jul 28, 2014
0
0
My husband beeps his tractor when he drives by the house these mornings on his way to feed cattle. It's his way to say he's thinking about me.
Mar 25, 2022
0
3
People who have tried unsuccessfully to prevent migraine with other treatments may find relief with a drug called erenumab, according to a preliminary study released today that will be presented at the American Academy of ...
Apr 17, 2018
0
85
